SeekingAlphaSeptember 4, 2026 at 6:19 AM NYLast Month
Avalo Therapeutics: Phase 2 Validation Has Created An IL-1β Franchise
Avalo Therapeutics (AVTX) is now a well-funded, registrational-stage biotech with validated Phase II data for abdakibart in hidradenitis suppurativa (HS).
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha
